【财联社早知道】广东省发文大力推进"人工智能+消费" 推动脑机接口等新技术新产品开发与应用推广,这家公司参 股的脑机接口公司的B端产品已正式在多家医院开展多中心 临床试验 一、脑机接口|广东省发文大力推进"人工智能+消费",推动脑机接口等新技术新产品开发与应用推广,机构预计2040年国内脑机 接口市场规模将超1200亿元,这家公司参股的脑机接口公司的B端产品已正式在多家医院开展多中心临床试验 据媒体报道,广东省人民政府办公厅发布关于印发广东省提振消费专项行动实施方案的通知,大力发展新型消费。深入实施数字 消费提升行动,深化即时电商应用,支持即时电商平台企业联合社区、商圈等构筑数字生活服务生态。支持直播电商平台创新虚 拟主播、3D直播间等带货模式。大力推进"人工智能+消费",推动自动驾驶、智能穿戴、超高清视频、脑帆接口、增材制造等新 技术新产品开发与应用推广。 点评:据机构预测,国内脑机接口市场规模预计到2040年将超过1200亿元,年复合增速高达26%，显示出巨大的发展潜力。东 吴证券发布研报称,政策专门把脑机接口纳入高成长性消费新赛道提出,一旦脑机接口技术成熟,快速进入临床应用的收费路径 已经铺好。侵入式技 ...

创业板指涨超1%，沪指涨0.26%，深成指涨0.53%，脑机接口、交运设备、保险、CPO等方向领涨，沪 深京三市上涨个股超3000只。 ...

脑机接口概念股盘初冲高，爱朋医疗（300753）涨超15%，荣泰健康（603579）、麒盛科技（603610） 涨停，南京熊猫（600775）、诚益通（300430）跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...

Core Viewpoint - The medical device sector is experiencing a significant recovery in investment and procurement activities, driven by supportive government policies and a release of pent-up demand for equipment updates starting from Q4 2024 [2][6][19]. Group 1: Industry Overview - The medical device market is set for a surge in equipment updates in the second half of 2024, with various provinces beginning to collect and update equipment [2][6]. - The demand for medical equipment updates is gradually being released, with hospitals and local governments announcing procurement projects since Q4 2024, leading to a noticeable increase in procurement scales [6][7]. - In Q1 2025, the total procurement scale for medical devices reached 545 billion yuan, a 53.09% increase quarter-on-quarter and a 16.45% increase year-on-year [7]. Group 2: Investment Dynamics - In Q1 2025, there were 87 financing cases in the medical device sector, a 27.40% increase quarter-on-quarter and a 4.49% increase year-on-year, with disclosed financing amounts totaling 8.202 billion yuan, marking a 129.62% increase quarter-on-quarter and a 96.93% increase year-on-year [19][21]. - The medical equipment sector attracted the most investor interest, with 58 financing cases totaling 6.054 billion yuan, particularly in treatment and medical imaging devices [19][20]. - The preference for mid-to-late stage financing has increased, with the share of early-stage financing cases dropping from 64.38% in Q4 2024 to 50.57% in Q1 2025, indicating a shift in investor sentiment towards larger, more established opportunities [20][27]. Group 3: Policy Support - Continuous government support for medical device procurement and updates is evident, with policies aimed at promoting large-scale equipment updates and enhancing the quality of healthcare resources at the grassroots level [6][9]. - Recent policies include the acceleration of clinical approvals for urgently needed medical devices, including high-end medical equipment and innovative medical devices [11][12]. - The government has emphasized the need for balanced distribution of medical resources and the enhancement of healthcare infrastructure, as outlined in the 2025 government work report [6][11]. Group 4: Key Investment Events - Notable financing events in Q1 2025 include significant rounds for companies like Fourier Intelligence (800 million yuan) and Pamu Medical (approximately 100 million USD) [16][33]. - The investment landscape shows a growing interest in rehabilitation devices and brain-computer interface technologies, reflecting the sector's innovative potential [19][44]. Group 5: Industry Trends - Brain-computer interface (BCI) technology is gaining traction, with a projected market size of 40 billion USD by 2030 and 145 billion USD by 2040, attracting significant investment and research [36][43]. - Clinical trials for BCI technologies are on the rise, with numerous trials registered globally, particularly in the treatment of neurological disorders [37][41]. - Domestic companies like Borui Kang are emerging as leaders in the BCI space, supported by favorable policies and advancements in technology [50][51].

Core Viewpoint - The external skeleton robot market is gaining traction, with significant interest from investors and a shift towards practical applications in various sectors, indicating a transition from validation to actual use [1][5]. Application Scenarios - External skeleton robots are wearable mechanical structures that assist or enhance users' movements, with applications expanding into tourism, healthcare, and industrial sectors [2][3]. - The "smart hiking stick" used in the Tai Mountain scenic area exemplifies the multifunctionality of these devices, offering walking assistance, health monitoring, and emergency features [2]. - The technology has evolved from passive to active products, integrating high-density sensors and adaptive algorithms for real-time user intent recognition [2]. Market Potential - The global market for external skeleton robots is projected to reach $14.67 billion by 2030, with a compound annual growth rate (CAGR) of 42.2% [4]. - Future applications are expected to extend into agriculture, logistics, and emergency services, with potential integration with cutting-edge technologies like brain-machine interfaces [4]. Industry Development Outlook - The market interest in external skeleton robots is rising, with over 50 inquiries on platforms like Shenzhen Stock Exchange's interactive platform, focusing on technology development and commercialization [5]. - Companies are actively responding to investor inquiries, showcasing advancements in AI, materials, and sensor technologies [5]. - Companies like Shenyang Siasun Robot & Automation Co., Ltd. are already in the demonstration phase of their wearable lower limb assistive devices in rehabilitation settings [5]. Product Development Progress - Zhejiang Precision Integrated Technology Co., Ltd. is testing single-joint external skeleton assistive robots in various scenarios, refining algorithms and product features [6]. - Companies are incorporating advanced materials like carbon fiber into their external skeleton robot structures to enhance performance [6]. Product Layout and Market Progress - Henan Xiangyu Medical Equipment Co., Ltd. is in the small-batch production phase of portable external skeleton assistive robots, aiming for medical device registration and market entry within the year [7]. - Jiangsu Zhenjiang New Energy Equipment Co., Ltd. plans to begin small-scale production of external skeleton robots in the third quarter of this year [7]. - Despite the promising market outlook, challenges such as technology, cost, and market dynamics remain, necessitating collaboration between industry, academia, and research to drive innovation and sustainable growth [7].

Group 1 - The market experienced a high opening followed by a decline, with the military and chemical sectors leading the gains, indicating accelerated rotation of themes [1][2][3] - The major indices showed a mixed performance, with the Shanghai Composite Index rising by 0.8% to 3342 points, while the Shenzhen Component and ChiNext Index increased by 0.22% and 0.51% respectively [1] - The total trading volume reached 1.47 trillion, an increase of 132.1 billion from the previous day, reflecting heightened market activity and intensified capital competition [1] Group 2 - The military sector saw significant gains due to the escalation of the India-Pakistan conflict and the accelerated commercialization of the domestic C919 aircraft, with stocks like Chenxi Aviation hitting the daily limit [2] - The chemical sector reached new highs, driven by price increase expectations for titanium dioxide and fertilizers, along with improved performance and sustained institutional inflows [3][4] - Other sectors such as robotics and new materials also showed strong performance, with stocks like Quanzhi Co. and Zhongxin Fluorine Material gaining attention [5][6] Group 3 - There was a noticeable decline in AI-related stocks, with concepts like Kimi and Nvidia experiencing significant drops, indicating a shift in market focus [7][8] - The overall sentiment in the market showed a preference for trending stocks, with notable interest in stocks that have shown consecutive gains [9] - The technology sector faced challenges, with the market reacting negatively to financial policies aimed at stabilizing expectations, leading to a mixed performance in tech stocks [11][12]

Core Viewpoint - Guangdong Province has released a significant policy aimed at boosting consumption, which includes measures to enhance property income channels, support for employee stock ownership plans, and various initiatives to stimulate consumer spending in sectors like automotive and healthcare [1][2][3]. Group 1: Consumption Enhancement Measures - The plan encourages listed companies to promote employee stock ownership plans and strengthens the market value management of state-owned enterprises to stabilize investor return expectations [1][2]. - It proposes to simplify the process for distributing childcare subsidies and encourages local governments to increase support for families with two or three children [1][2]. - The policy aims to expand automotive consumption by relaxing vehicle purchase restrictions and increasing car purchase quotas in cities like Guangzhou and Shenzhen [1][3]. Group 2: Real Estate and Housing Policies - The government will utilize its autonomy in real estate regulation to adjust restrictive measures related to purchasing, transferring, and financing properties, aiming to stabilize the real estate market [3]. - There is a commitment to increase the supply of affordable housing and to support the renovation of old residential areas, with a target of starting renovations on at least 600 old communities by 2025 [3]. Group 3: Technological and Health Consumption - The initiative promotes the integration of artificial intelligence in various consumer sectors, including healthcare and education, and aims to enhance remote medical services [4]. - It supports the development of new consumption models, such as the "old for new" policy for consumer goods, which includes subsidies for replacing old appliances [4]. Group 4: Financial Support for Consumption - The policy encourages financial institutions to increase personal consumption loans while ensuring risk control, allowing for higher loan amounts and extended repayment periods for creditworthy customers [5]. - It also promotes the establishment of duty-free shops and tax refund services to enhance international consumer experiences in cities like Guangzhou and Shenzhen [5]. Group 5: Market Response and Investment Opportunities - Recent data indicates a robust recovery in domestic tourism and spending, with a 6.4% increase in travel and an 8.0% rise in total spending during the holiday period [6]. - Analysts suggest that the ongoing policy support for consumption will benefit sectors such as dining, travel, and retail, with a focus on service consumption as a key area for future growth [6][7].

Investment Rating - Investment rating: Buy (maintained) [2][8] Core Views - The company is facing short-term pressure on performance in 2024, but is increasing R&D investment to build long-term advantages [2][6] - The company reported a revenue of 744 million yuan in 2024, a slight decrease of 0.17% year-on-year, and a net profit attributable to shareholders of 103 million yuan, down 54.68% year-on-year [6][9] - The company is focusing on the rehabilitation sector, which has significant long-term potential, while experiencing short-term profit pressure due to rising expense ratios [6][9] Financial Performance Summary - 2024 revenue: 744 million yuan (yoy -0.17%); net profit: 103 million yuan (yoy -54.68%); non-recurring net profit: 89.97 million yuan (yoy -55.90%) [6][11] - Q4 2024 revenue: 237 million yuan (yoy +16.74%); net profit: 29.53 million yuan (yoy -38.45%); non-recurring net profit: 25.54 million yuan (yoy -35.06%) [6][11] - Q1 2025 revenue: 186 million yuan (yoy +10.02%); net profit: 22.95 million yuan (yoy -41.26%); non-recurring net profit: 18.71 million yuan (yoy -48.72%) [6][11] Expense and Profitability Metrics - Sales expense ratio: 28.91% (yoy +6.10pct); management expense ratio: 8.10% (yoy +2.60pct); R&D expense ratio: 20.45% (yoy +6.12pct) [6][9] - Gross margin: 67.42%, down 1.20 pct year-on-year; net margin: 13.83%, down 16.82 pct year-on-year [6][9] R&D Investment and Future Outlook - R&D investment in 2024 was 152 million yuan, an increase of 42.41% year-on-year, accounting for 20.45% of total revenue [6][9] - The company has established multiple R&D centers and is focusing on advanced technologies such as brain-machine interfaces and rehabilitation robotics [7][9] - Revenue projections for 2025-2027 are 848 million yuan, 972 million yuan, and 1.121 billion yuan, with growth rates of 14.1%, 14.6%, and 15.3% respectively [8][11] Earnings Per Share and Valuation - Expected EPS for 2025-2027: 0.94 yuan, 1.21 yuan, and 1.57 yuan, with corresponding P/E ratios of 38x, 29x, and 23x [9][11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][8] Core Views - The company's performance is under short-term pressure in 2024, but increased R&D investment is expected to build long-term advantages [2][6] - The company reported a revenue of 744 million yuan in 2024, a year-on-year decrease of 0.17%, and a net profit attributable to shareholders of 103 million yuan, down 54.68% year-on-year [6][9] - The company is focusing on the rehabilitation sector, which has significant long-term potential despite short-term profit pressures due to rising expense ratios [6][9] Financial Performance Summary - In 2024, the company achieved a revenue of 744 million yuan, with a year-on-year change of -0.17% [6][11] - The net profit attributable to shareholders was 103 million yuan, reflecting a year-on-year decline of 54.68% [6][11] - The company’s gross margin was 67.42%, down 1.20 percentage points year-on-year, and the net margin was 13.83%, down 16.82 percentage points year-on-year [6][11] - R&D expenses increased by 42.41% year-on-year to 152 million yuan, representing 20.45% of total revenue [6][11] Revenue Breakdown - Revenue from rehabilitation therapy equipment was 504 million yuan, up 9.85% year-on-year [6][9] - Revenue from rehabilitation training equipment was 165 million yuan, down 19.89% year-on-year [6][9] - Revenue from rehabilitation assessment equipment was 27.62 million yuan, down 21.92% year-on-year [6][9] Future Projections - Revenue projections for 2025, 2026, and 2027 are 848 million yuan, 972 million yuan, and 1.121 billion yuan, respectively, with growth rates of 14.1%, 14.6%, and 15.3% [8][11] - Net profit projections for the same years are 151 million yuan, 194 million yuan, and 251 million yuan, with growth rates of 46.5%, 28.8%, and 29.3% [8][11] - The expected EPS for 2025, 2026, and 2027 are 0.94 yuan, 1.21 yuan, and 1.57 yuan, respectively [8][11]

Military Industry - Companies like 恒天海龙 and 华伍股份 have shown significant stock increases, with 恒天海龙 rising by 10.07% and 华伍股份 by 19.94%, driven by military and aerospace sectors [2][3] - The stock of 成飞集成 increased by 9.98%, indicating strong interest in military technology [2] - Companies such as 通易航天 and 中航成飞 also reported substantial gains, with increases of 25.11% and 17.05% respectively, reflecting a robust military industry outlook [3] Chemical Industry - 红墙股份 has maintained a strong performance with a 9.97% increase over 12 trading days, attributed to the rising prices of epoxy propylene [4] - 中欣氟材 also performed well, with a 9.99% increase over 9 days, linked to fluorochemical products [4] - The chemical sector is experiencing volatility, leading to increased market attention on companies like 丹化科技 and 长华化学, which reported gains of 9.93% and 20.02% respectively [4] AI Computing Power - The AI computing power sector is showing strong performance, with companies like 全筑股份 and 电光科技 increasing by 10.00% and 10.01% respectively, driven by advancements in server technology [8] - The report indicates that the AI computing industry remains in a high-growth phase, supported by positive earnings reports from related companies [7] Robotics - The introduction of exoskeleton robots in tourist attractions has led to increased interest in robotics companies, with 中超控股 and 龙溪股份 both achieving gains of 10.09% and 10.01% respectively [10][11] - The sector is benefiting from growing consumer interest and technological advancements in robotic applications [10] Brain-Computer Interface - Neuralink's breakthrough with its brain-computer interface device has garnered attention, with stocks like 童畫頁 and 麒盛科技 rising by 9.98% and 10.00% respectively, reflecting optimism in brain technology [13][14] Performance Surprises - Companies like 润贝航科 and 渝三峡 A have shown strong stock performance, with 润贝航科 increasing by 10.01% over 12 days, indicating positive market sentiment following earnings reports [15][16] Semiconductor Industry - The semiconductor equipment sector is expected to benefit from increased domestic investment in photolithography technology, with stocks like 京运通 and 奥普光电 rising by 9.92% and 10.00% respectively [18][19] Agricultural Planting - The new regulations on plant variety protection are expected to positively impact agricultural companies, with stocks like 秋乐种业 and 康农种业 showing increases of 17.90% and 10.24% respectively [20][21] Food and Beverage - The announcement of a 500 billion yuan loan facility to support consumption is likely to benefit food and beverage companies, with stocks like 保龄宝 and 一致魔芋 rising by 9.96% and 21.20% respectively [22][24] Real Estate - The reduction in housing loan interest rates is expected to stimulate the real estate market, with stocks like 三湘印象 and 天保基建 increasing by 10.14% and 10.10% respectively [25][26]